788 related articles for article (PubMed ID: 23416119)
21. Protective effect of a Chinese Medicine formula He-Ying-Qing-Re Formula on diabetic retinopathy.
Wang L; Wang N; Tan HY; Zhang Y; Feng Y
J Ethnopharmacol; 2015 Jul; 169():295-304. PubMed ID: 25929449
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease.
Vinores SA; Youssri AI; Luna JD; Chen YS; Bhargave S; Vinores MA; Schoenfeld CL; Peng B; Chan CC; LaRochelle W; Green WR; Campochiaro PA
Histol Histopathol; 1997 Jan; 12(1):99-109. PubMed ID: 9046048
[TBL] [Abstract][Full Text] [Related]
23. Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes.
Navaratna D; McGuire PG; Menicucci G; Das A
Diabetes; 2007 Sep; 56(9):2380-7. PubMed ID: 17536065
[TBL] [Abstract][Full Text] [Related]
24. [Angiopathy and the eye].
Rencová E
Vnitr Lek; 2010 Apr; 56(4):333-9. PubMed ID: 20465107
[TBL] [Abstract][Full Text] [Related]
25. Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown.
Edelman JL; Lutz D; Castro MR
Exp Eye Res; 2005 Feb; 80(2):249-58. PubMed ID: 15670803
[TBL] [Abstract][Full Text] [Related]
26. Regulation of blood-retinal barrier cell-junctions in diabetic retinopathy.
Rudraraju M; Narayanan SP; Somanath PR
Pharmacol Res; 2020 Nov; 161():105115. PubMed ID: 32750417
[TBL] [Abstract][Full Text] [Related]
27. Glucocorticoid regulation of endothelial cell tight junction gene expression: novel treatments for diabetic retinopathy.
Felinski EA; Antonetti DA
Curr Eye Res; 2005 Nov; 30(11):949-57. PubMed ID: 16282129
[TBL] [Abstract][Full Text] [Related]
28. Blood-retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management.
Kaur C; Foulds WS; Ling EA
Prog Retin Eye Res; 2008 Nov; 27(6):622-47. PubMed ID: 18940262
[TBL] [Abstract][Full Text] [Related]
29. Ultrastructural localization of blood-retinal barrier breakdown in diabetic and galactosemic rats.
Vinores SA; McGehee R; Lee A; Gadegbeku C; Campochiaro PA
J Histochem Cytochem; 1990 Sep; 38(9):1341-52. PubMed ID: 2117624
[TBL] [Abstract][Full Text] [Related]
30. Cellular mechanisms of blood-retinal barrier dysfunction in macular edema.
Vinores SA; Derevjanik NL; Ozaki H; Okamoto N; Campochiaro PA
Doc Ophthalmol; 1999; 97(3-4):217-28. PubMed ID: 10896335
[TBL] [Abstract][Full Text] [Related]
31. Quantitative assessment of the integrity of the blood-retinal barrier in mice.
Derevjanik NL; Vinores SA; Xiao WH; Mori K; Turon T; Hudish T; Dong S; Campochiaro PA
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2462-7. PubMed ID: 12091451
[TBL] [Abstract][Full Text] [Related]
32. [Tyndallometry in patients with diabetic macular edema before and after central laser coagulation].
Wiedemann R; Walter A; Wiedemann P
Klin Monbl Augenheilkd; 1998 Jan; 212(1):32-6. PubMed ID: 9541892
[TBL] [Abstract][Full Text] [Related]
33. [Patophysiology of diabetic retinopathy].
Kolár P
Vnitr Lek; 2013 Mar; 59(3):173-6. PubMed ID: 23713183
[TBL] [Abstract][Full Text] [Related]
34. Dynamic contrast enhanced MRI in patients with diabetic macular edema: initial results.
Trick GL; Liggett J; Levy J; Adamsons I; Edwards P; Desai U; Tofts PS; Berkowitz BA
Exp Eye Res; 2005 Jul; 81(1):97-102. PubMed ID: 15978260
[TBL] [Abstract][Full Text] [Related]
35. RETINAL VASCULAR CYSTOID MACULAR EDEMA: Review and New Theory.
Spaide RF
Retina; 2016 Oct; 36(10):1823-42. PubMed ID: 27328171
[TBL] [Abstract][Full Text] [Related]
36. VEGF-TRAP(R1R2) suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier.
Saishin Y; Saishin Y; Takahashi K; Lima e Silva R; Hylton D; Rudge JS; Wiegand SJ; Campochiaro PA
J Cell Physiol; 2003 May; 195(2):241-8. PubMed ID: 12652651
[TBL] [Abstract][Full Text] [Related]
37. A systematic correlation of angiography and high-resolution optical coherence tomography in diabetic macular edema.
Bolz M; Ritter M; Schneider M; Simader C; Scholda C; Schmidt-Erfurth U
Ophthalmology; 2009 Jan; 116(1):66-72. PubMed ID: 19118697
[TBL] [Abstract][Full Text] [Related]
38. An adenosine agonist and prostaglandin E1 cause breakdown of the blood-retinal barrier by opening tight junctions between vascular endothelial cells.
Vinores SA; Sen H; Campochiaro PA
Invest Ophthalmol Vis Sci; 1992 May; 33(6):1870-8. PubMed ID: 1582791
[TBL] [Abstract][Full Text] [Related]
39. Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats.
Kusari J; Zhou S; Padillo E; Clarke KG; Gil DW
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5152-9. PubMed ID: 17962468
[TBL] [Abstract][Full Text] [Related]
40. Protective effect of clusterin on blood-retinal barrier breakdown in diabetic retinopathy.
Kim JH; Kim JH; Yu YS; Min BH; Kim KW
Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1659-65. PubMed ID: 19875648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
